Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Change in Cash (2023 - 2025)

Onconetix (ONCO) has disclosed Change in Cash for 2 consecutive years, with $305005.0 as the latest value for Q4 2024.

  • On a quarterly basis, Change in Cash rose 109.84% to $305005.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$3.9 million, a 81.57% increase, with the full-year FY2024 number at -$3.9 million, up 81.57% from a year prior.
  • Change in Cash was $305005.0 for Q4 2024 at Onconetix, up from -$589046.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $305005.0 in Q4 2024 to a low of -$12.0 million in Q2 2023.